We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$144B
AUM Growth
+$2.8B
(+2%)
Cap. Flow
-$5.9B
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
347
New
10
Increased
58
Reduced
237
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$187M |
| 2 |
Intel
INTC
|
+$174M |
| 3 |
Aurora
AUR
|
+$114M |
| 4 |
Alibaba
BABA
|
+$86.2M |
| 5 |
Pulmonx
LUNG
|
+$72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$763M |
| 2 |
Tesla
TSLA
|
+$478M |
| 3 |
Adobe
ADBE
|
+$327M |
| 4 |
Microsoft
MSFT
|
+$319M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 26% |
| 3 | Industrials | 11.45% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
American Homes 4 Rent
AMH
$12.5B
| $26.8M | 0.02% |
613,850
-13,000
| -2% | -$527K |
|
227
Kirby Corp
KEX
$6.93B
| $26.3M | 0.02% |
442,600
-4,200
| -0.9% | -$235K |
|
228
Dell
DELL
$293B
| $26.1M | 0.02% |
464,310
-460,179
| -50% | -$25.7M |
|
|
TPTX
229
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $25.9M | 0.02% |
544,010
+24,380
| +5% | +$1.09M |
|
230
Danaher
DHR
$144B
| $24.8M | 0.02% |
85,193
| – | – |
|
231
Gibraltar Industries
ROCK
$1.49B
| $24.7M | 0.02% |
371,100
| – | – |
|
232
GSK
GSK
$106B
| $24.3M | 0.02% |
441,120
| – | – |
|
233
Glaukos
GKOS
$10.6B
| $23.7M | 0.02% |
532,900
+32,700
| +7% | +$1.51M |
|
|
DOOR
234
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $23.5M | 0.02% |
199,200
+2,000
| +1% | +$229K |
|
235
Rapid7
RPD
$773M
| $23.5M | 0.02% |
199,420
-5,680
| -3% | -$701K |
|
236
Leslie's
LESL
$11M
| $23.1M | 0.02% |
+48,840
| New | +$21.1M |
|
237
Enovis
ENOV
$1.53B
| $22.6M | 0.02% |
285,736
-56,822
| -17% | -$4.75M |
|
238
IMAX
IMAX
$2.66B
| $22.1M | 0.02% |
1,239,500
-99,900
| -7% | -$1.92M |
|
|
OPTU
239
Optimum Communications Inc
OPTU
$301M
| $21.8M | 0.02% |
1,346,300
+17,700
| +1% | +$300K |
|
|
GTM
240
ZoomInfo Technologies
GTM
$1.22B
| $20.3M | 0.01% |
315,969
-4,720
| -1% | -$316K |
|
241
GitLab
GTLB
$6.58B
| $20M | 0.01% |
+230,200
| New | +$23.6M |
|
242
Standard BioTools
LAB
$314M
| $20M | 0.01% |
5,093,403
-169,640
| -3% | -$794K |
|
243
Guardant Health
GH
$22.6B
| $19.7M | 0.01% |
196,652
| – | – |
|
244
Cameco
CCJ
$42.4B
| $19.4M | 0.01% |
890,400
+28,200
| +3% | +$682K |
|
245
Merck
MRK
$318B
| $18.7M | 0.01% |
243,700
-268,700
| -52% | -$21.4M |
|
246
Comscore
SCOR
$109M
| $18.2M | 0.01% |
272,381
-971
| -0.4% | -$69.5K |
|
|
FOLD
247
DELISTED
Amicus Therapeutics
FOLD
| $17.6M | 0.01% |
1,528,000
-98,100
| -6% | -$1.09M |
|
248
BridgeBio Pharma
BBIO
$16.5B
| $17.5M | 0.01% |
1,050,740
+589,880
| +128% | +$25M |
|
|
GAN
249
DELISTED
GAN Ltd
GAN
| $17.4M | 0.01% |
1,890,785
| – | – |
|
250
Waters Corp
WAT
$39.9B
| $17.1M | 0.01% |
45,900
-300
| -0.6% | -$105K |
|
Similar funds
VAM
Primecap Management's Q4 2021 Portfolio in Review
As of Q4 2021, Primecap Management held 347 positions worth $144B, up 2% from $142B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management withdrew a net $5.9B in Q4 2021, closing 5 positions and reducing 237 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Aurora worth $116M.
- Primecap Management's largest Q4 2021 buy was Aurora: 10,279,870 shares worth $116M.
- Primecap Management added most to Bristol-Myers Squibb in Q4 2021, an estimated $187M increase.
- Primecap Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $763M.
- Primecap Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $10M.
- Primecap Management's ten largest holdings make up 30% of its $144B portfolio in Q4 2021.
- Primecap Management opened 10 new positions and closed 5 in Q4 2021.
- Primecap Management's portfolio value rose 2% quarter-over-quarter to $144B.
Based on Primecap Management's 13F filing for Q4 2021, filed 11 Feb 2022.